Per- and polyfluorinated alkyl substances (PFAS) have been widely used in the manufacture of medical devices for their unique properties, such as resistance to heat, chemicals, and friction.
But with growing evidence of their environmental and health risks, PFAS are now at the centre of intense regulatory scrutiny worldwide.
Join us during BSI’s Healthcare Week 2025 for a free, focused webinar on the phase-out of PFAS and its profound implications for the medical device industry.
With an EU-wide ban proposed by 2030 and major suppliers already discontinuing production, understanding the compliance landscape and preparing for transition is critical.
Why Attend?
- Get ahead of regulatory timelines. Learn about the timeline of upcoming PFAS restrictions, including the EU’s 2030 phase-out plan.
- Understand strategic next steps. Discover what manufacturers can do now to begin transitioning, including how to engage with Notified and Approved Bodies (NB/AB).
- Anticipate compliance implications. Examine how the withdrawal of PFAS affects CE marking and broader regulatory pathways under MDR, IVDR, and UKCA.
- Gain industry insight. Benefit from expert guidance designed for manufacturers, consultants, and academic stakeholders invested in sustainable innovation and regulatory leadership.
Webinar details:
Date: 10 June 2025
Time: 12:00 - 13:00 BST
Location: Online
Agenda:
Introductions
PFAS Overview
Upcoming Challenges related to phase out of PFAS
PFAS regulatory landscape and restrictions
Impact on Medical Devices
Next Steps
